News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
755,016 Results
Type
Article (54473)
Company Profile (412)
Press Release (700131)
Section
Business (219911)
Career Advice (2909)
Deals (38019)
Drug Delivery (115)
Drug Development (87310)
Employer Resources (184)
FDA (17293)
Job Trends (16283)
News (373719)
Policy (36341)
Tag
Academia (2911)
Alliances (53610)
Alzheimer's disease (1352)
Approvals (17205)
Artificial intelligence (166)
Bankruptcy (382)
Best Places to Work (12252)
Biotechnology (276)
Breast cancer (197)
Cancer (1411)
Cardiovascular disease (121)
Career advice (2440)
Cell therapy (298)
Clinical research (69477)
Collaboration (479)
Compensation (253)
COVID-19 (2784)
C-suite (118)
Data (1394)
Diabetes (179)
Diagnostics (6583)
Earnings (89125)
Employer resources (161)
Events (119554)
Executive appointments (383)
FDA (17951)
Funding (429)
Gene therapy (215)
GLP-1 (708)
Government (4844)
Healthcare (20151)
Infectious disease (2879)
Inflammatory bowel disease (125)
Interviews (559)
IPO (17150)
Job creations (4451)
Job search strategy (2024)
Layoffs (476)
Legal (8999)
Lung cancer (205)
Manufacturing (215)
Medical device (13990)
Medtech (13995)
Mergers & acquisitions (20978)
Metabolic disorders (500)
Neuroscience (1697)
NextGen Class of 2024 (7209)
Non-profit (4914)
Northern California (1677)
Obesity (290)
Opinion (236)
Patents (123)
People (61892)
Pharmaceutical (110)
Phase I (21543)
Phase II (30429)
Phase III (22837)
Pipeline (516)
Postmarket research (2987)
Preclinical (9241)
Radiopharmaceuticals (255)
Rare diseases (279)
Real estate (6649)
Regulatory (24012)
Research institute (2578)
Resumes & cover letters (461)
Southern California (1459)
Startups (3967)
United States (15446)
Vaccines (650)
Weight loss (227)
Date
Last 7 days (708)
Last 30 days (2658)
Last 365 days (37230)
2024 (36377)
2023 (42100)
2022 (53394)
2021 (58094)
2020 (56916)
2019 (50189)
2018 (38038)
2017 (35171)
2016 (35225)
2015 (41226)
2014 (35449)
2013 (30748)
2012 (32662)
2011 (33234)
2010 (31387)
Location
Africa (953)
Arizona (208)
Asia (44159)
Australia (7702)
California (3808)
Canada (1424)
China (305)
Colorado (173)
Connecticut (184)
Europe (97017)
Florida (528)
Georgia (134)
Illinois (411)
Indiana (232)
Maryland (656)
Massachusetts (3029)
Michigan (179)
Minnesota (303)
New Jersey (1102)
New York (1074)
North Carolina (822)
Northern California (1677)
Ohio (150)
Pennsylvania (917)
South America (1353)
Southern California (1459)
Texas (552)
Utah (110)
Washington State (412)
755,016 Results for "s1 biopharma formerly known as s1 pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
Evidence Mounts for Potential of GLP-1s in Alzheimer’s Disease
The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.
December 9, 2024
·
6 min read
·
Heather McKenzie
Press Releases
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
December 2, 2024
·
3 min read
Drug shortages
Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability
Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded pharmacies are still making them. That’s unprecedented.
November 26, 2024
·
4 min read
·
Ben Hargreaves
Press Releases
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA
September 3, 2024
·
3 min read
Weight Loss
Novo’s Next-Gen CB1 Drug Leads to Weight Loss in Phase II, but Neuropsychiatric Events Reported
Novo Nodrisk’s cannabinoid receptor–targeting obesity pill was picked up in the $1.1 billion acquisition of Inversago Pharmaceuticals last year.
September 20, 2024
·
2 min read
·
Annalee Armstrong
Podcast
Layoffs Persist, GLP-1s Launch for Weight Loss in China
Despite early 2024 optimism,
BioSpace
’s Job Market Trends report outlines a still sluggish situation in the biopharma industry, Novartis and J&J announce Q2 earnings, GLP-1 market leaders expand into China and the Cassava Sciences saga continues.
July 24, 2024
·
1 min read
·
Heather McKenzie
Podcast
Lilly’s I&I Play, ADC Investment and GLP-1 Momentum Persists
Eli Lilly becomes the latest to make a major investment in immunology and inflammation, while antibody-drug conjugate biopharma Myricx Bio nets a large Series A round and new research highlights the potential and possible risks of GLP-1s.
July 10, 2024
·
1 min read
·
Greg Slabodkin
Job Trends
BioSpace
Announces 2025 Best Places to Work in Biopharma
BioSpace
has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
November 12, 2024
·
6 min read
·
Angela Gabriel
Press Releases
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
December 3, 2024
·
8 min read
Press Releases
Christina Iskandar has been appointed as associate director of human resources at GC Biopharma USA Inc.
November 25, 2024
·
2 min read
1 of 75,502
Next
